These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 14697940)

  • 1. Gastric emptying time in renal transplant recipients treated with cyclosporine.
    Ozkaya O; Derici U; Buyan N; Dalgic A; Dalgic B; Cingi E; Kitapci M; Sindel S; Hasanoglu E
    Transplant Proc; 2003 Dec; 35(8):2927-30. PubMed ID: 14697940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in gastric motor activity in renal transplant recipients treated with FK-506 versus cyclosporine.
    Maes BD; Vanwalleghem J; Kuypers D; Ghoos Y; Rutgeerts PJ; Vanrenterghem YF
    Transplantation; 1999 Nov; 68(10):1482-5. PubMed ID: 10589943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of SDZ RAD vs. MMF on gastric emptying in renal transplant recipients.
    Maes BD; Evenepoel P; Kuypers D; Geypens B; Ghoos Y; Vanrenterghem Y
    Clin Transplant; 2003 Jun; 17(3):171-6. PubMed ID: 12780664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of impaired renal function in heart transplant recipients treated with mycophenolate mofetil and low-dose cyclosporine.
    Aleksic I; Baryalei M; Busch T; Pieske B; Schorn B; Strauch J; Sîrbu H; Dalichau H
    Transplantation; 2000 Apr; 69(8):1586-90. PubMed ID: 10836367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful withdrawal of steroids in pediatric renal transplant recipients receiving cyclosporine A and mycophenolate mofetil treatment: results after four years.
    Höcker B; John U; Plank C; Wühl E; Weber LT; Misselwitz J; Rascher W; Mehls O; Tönshoff B
    Transplantation; 2004 Jul; 78(2):228-34. PubMed ID: 15280683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythrocyte sodium lithium countertransport in renal transplant recipients with mycophenolate mofetil and low-dose cyclosporine.
    Vareesangthip K; Hanlakorn P; Suwannaton L; Larpkitkachorn R; Chuawattana D; Pidetcha P; Ong-Aj-Yooth L
    Transplant Proc; 2004 Dec; 36(10):3032-5. PubMed ID: 15686688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in immunosuppressive therapy: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS).
    Benfield MR; Stablein D; Tejani A
    Pediatr Transplant; 1999 Feb; 3(1):27-32. PubMed ID: 10359028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized trial of tacrolimus + mycophenolate mofetil or azathioprine versus cyclosporine + mycophenolate mofetil after cadaveric kidney transplantation: results at three years.
    Gonwa T; Johnson C; Ahsan N; Alfrey EJ; Halloran P; Stegall M; Hardy M; Metzger R; Shield C; Rocher L; Scandling J; Sorensen J; Mulloy L; Light J; Corwin C; Danovitch G; Wachs M; VanVeldhuisen P; Leonhardt M; Fitzsimmons WE
    Transplantation; 2003 Jun; 75(12):2048-53. PubMed ID: 12829910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycophenolate mofetil, an alternative to cyclosporine A for long-term immunosuppression in kidney transplantation?
    Houde I; Isenring P; Boucher D; Noël R; Lachanche JG
    Transplantation; 2000 Oct; 70(8):1251-3. PubMed ID: 11063351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal function and safety of heart transplant recipients switched to mycophenolate mofetil and low-dose cyclosporine.
    Baryalei M; Zenker D; Pieske B; Tondo K; Dalichau H; Aleksic I
    Transplant Proc; 2003 Jun; 35(4):1539-42. PubMed ID: 12826215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New concepts in cyclosporine pharmacokinetic and dynamic monitoring: the impact of concomitant immunosuppression on target C2 concentrations.
    Brunet M; Millán O; Jiménez O; Campistol JM; Vidal E; Rojo I; Oppenheimer F; Fortuna V; Martorell J
    Transplant Proc; 2004 Mar; 36(2 Suppl):437S-441S. PubMed ID: 15041382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome in cadaveric renal transplant recipients treated with cyclosporine A and mycophenolate mofetil versus cyclosporine A and azathioprine.
    Lee CM; Markezich AJ; Scandling JD; Dafoe DC; Alfrey EJ
    J Surg Res; 1998 May; 76(2):131-6. PubMed ID: 9698512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective randomised study of CSA monotherapy versus CSA plus mycophenolate mofetil in cadaveric renal transplant recipients.
    Sells RA; Bakran A; Brown MW; Grinyo J; Hammad A; Hyatt D; Owens G
    Transplant Proc; 1998 Dec; 30(8):4098. PubMed ID: 9865311
    [No Abstract]   [Full Text] [Related]  

  • 14. The impact of mycophenolate mofetil versus azathioprine as adjunctive therapy to cyclosporine on the rates of renal allograft loss due to glomerular disease recurrence.
    Pham PT; Pham PC
    Nephrol Dial Transplant; 2012 Jul; 27(7):2965-71. PubMed ID: 22207327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized trial with steroids and antithymocyte globulins comparing cyclosporine/azathioprine versus tacrolimus/mycophenolate mofetil (CATM2) in renal transplantation.
    Vacher-Coponat H; Moal V; Indreies M; Purgus R; Loundou A; Burtey S; Brunet P; Moussi-Frances J; Daniel L; Dussol B; Berland Y
    Transplantation; 2012 Feb; 93(4):437-43. PubMed ID: 22228415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of mycophenolate mofetil combined with very low-dose cyclosporine microemulsion in long-term liver-transplant patients with renal dysfunction.
    Cantarovich M; Tzimas GN; Barkun J; Deschênes M; Alpert E; Tchervenkov J
    Transplantation; 2003 Jul; 76(1):98-102. PubMed ID: 12865793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cinacalcet's effect on the pharmacokinetics of tacrolimus, cyclosporine and mycophenolate in renal transplant recipients.
    Falck P; Vethe NT; Asberg A; Midtvedt K; Bergan S; Reubsaet JL; Holdaas H
    Nephrol Dial Transplant; 2008 Mar; 23(3):1048-53. PubMed ID: 17956893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycophenolate mofetil and reduction in cyclosporine dosage for chronic renal allograft dysfunction.
    Islam MS; Francos GC; Dunn SR; Burke JF
    Transplant Proc; 1998 Aug; 30(5):2230-1. PubMed ID: 9723452
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of chronic rejection in renal transplantation by mycophenolate mofetil (MMF): a preliminary report of six-month experience.
    Jirasiritham S; Sumethkul V; Mavichak V; Jirasiritham S; Chiewsilp P; Leenanupunth C; Kochakarn W
    Transplant Proc; 1998 Nov; 30(7):3576-7. PubMed ID: 9838566
    [No Abstract]   [Full Text] [Related]  

  • 20. Trough levels of mycophenolic acid and its glucuronidated metabolite in renal transplant recipients.
    Merkel U; Lindner S; Vollandt R; Sperschneider H; Balogh A
    Int J Clin Pharmacol Ther; 2005 Aug; 43(8):379-88. PubMed ID: 16119513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.